Drug Trial Radar · NCT03322566
A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)
Last checked: Nov 19, 2026Latest source record: Jan 24, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
233
Actual
Start
Jan 9, 2018
Primary completion
Dec 13, 2018
Study completion Oct 16, 2020
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- Collaborators
- Merck Sharp & Dohme LLC
- First posted
- Oct 26, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to evaluate the efficacy and safety of pembrolizumab plus epacadostat with platinum-based chemotherapy versus pembrolizumab plus platinum-based chemotherapy plus placebo as first-line therapy in participants with metastatic non-small cell lung cancer (NSCLC).
Conditions
- Lung Cancer
Interventions
PembrolizumabDrug
Pembrolizumab administered intravenously every 3 weeks.
EpacadostatDrug
Epacadostat administered orally twice daily.
Platinum-based chemotherapyDrug
Investigator selected one of the following regimens: pemetrexed + cisplatin, pemetrexed + carboplatin, or paclitaxel + carboplatin, depending on histology.
PlaceboDrug
Matching placebo administered orally twice daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR) of Pembrolizumab + Chemotherapy + Epacadostat Versus Pembrolizumab + Chemotherapy + PlaceboTime frame: Assessed every 12 weeks up to 24 months
Locations
94 sites in 14 countries. Site status is shown where the registry gives one.
Southern Cancer Center, PC
Daphne, Alabama
Western Regional Medical Center, Inc.
Goodyear, Arizona
Arizona Oncology Associates PC- HOPE
Tucson, Arizona
Lynn Cancer Institute
Boca Raton, Florida
Florida Cancer Specialists (South Region)
Fort Myers, Florida
Florida Cancer Specialists (North Region)
St. Petersburg, Florida
PPG-Oncology
Fort Wayne, Indiana
University of Michigan
Ann Arbor, Michigan
MMCORC
Saint Louis Park, Minnesota
St. Vincent Healthcare Frontier Cancer Center
Billings, Montana
New York Oncology Hematology P.C
Albany, New York
Oncology Hematology Care, Inc.
Cincinnati, Ohio
Southwestern Regional Medical Center, Inc.
Tulsa, Oklahoma
St. Luke's Hospital - Anderson Campus
Easton, Pennsylvania
Allegheny General Hospital
Pittsburgh, Pennsylvania
Tennessee Oncology, PLLC/The Sarah Cannon Research Institute
Chattanooga, Tennessee
Tennessee Oncology, PLLC/The Sarah Cannon Research Institute
Nashville, Tennessee
Texas Oncology-Denton South
Denton, Texas
Oncology & Hematology Assoc. SW Virginia, Inc., DBA Blue Ridge Cancer Care
Blacksburg, Virginia
Emily Couric Clinical Cancer Center
Charlottesville, Virginia
Seattle Cancer Care Alliance
Seattle, Washington
Blacktown Hospital
Blacktown, New South Wales, Australia
Chris OBrien Lifehouse
Camperdown, New South Wales, Australia
The Crown Princess Mary Cancer Centre Westmead
Westmead, New South Wales, Australia
Southern Medical Day Care Centre
Wollongong, New South Wales, Australia
MNCCI Port Macquarie Base Hospital
Port Macquarie, New South Wales (Australia), Australia
Cairns Base Hospital
Cairns, Queensland, Australia
BCCA-Cancer Centre of the Southern Interior
Kelowna, British Columbia, Canada
Lions Gate Hospital
North Vancouver, British Columbia, Canada
CISSS de la Monteregie-Centre
Greenfield Park, Quebec, Canada
CSSS de Laval- Hopital de la Cite de la Sante
Laval, Quebec, Canada
CIUSSS Ouest de l'Ile - St-Mary's Hospital
Montreal, Quebec, Canada
CIUSSS du Nord-de-l'ILe-de-Montreal Hopital du Sacre-Coeur de Montreal
Montreal, Quebec, Canada
CHU de Quebec - Hotel-Dieu de Quebec
Québec, Quebec, Canada
CIUSSS de la Mauricie-et-du-Centre-du-Quebec
Trois-Rivières, Quebec, Canada
Orszagos Koranyi TBC es Pulmonologiai Intezet
Budapest, Hungary
Veszprem Megyei Tudogyogyintezet
Farkasgyepű, Hungary
Bekes Megyei Pandy Kalman Korhaz
Gyula, Hungary
CRU Hungary Kft.
Miskolc, Hungary
Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet
Szolnok, Hungary
Showing 40 of 94 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.